- About Us
- Advertise
- Editorial Information
- Contact Us
- Do Not Sell My Personal Information
- Privacy Policy
- Terms and Conditions
© 2024 MJH Life Sciences™ and BioPharm International. All rights reserved.
BioPharm International-03-01-2019
BioPharm International
Regulatory Considerations Associated with Alternative Dosage Forms
March 02, 2019
Features
32
3
Jessica Rousset, chief operating officer, CURE Pharmaceutical, highlights some key regulatory considerations developers should keep in mind when approaching alternative dosage forms.
Successfully Moving Regulated Data to the Cloud
March 01, 2019
Features
32
3
In light of recent FDA guidance on data integrity, the challenges and benefits of using the public cloud to deploy and use data management software are discussed.
Strategic Ventures Reflect Dynamic Growth in China
March 01, 2019
Global News
32
3
Technology vendors are strengthening their positions in China as the nation emphasizes self-sufficiency in research, development, and manufacturing.
CMOs Leading the Way on Single-Use Systems Adoption
March 01, 2019
Perspectives on Outsourcing
32
3
Single-use systems can be a cost savings for CMOs, and these savings can be passed on to clients and, ultimately, to patients.
Cell and Gene Therapies Gain Streamlined FDA Oversight
March 01, 2019
Regulatory Beat
32
3
FDA expects more than 200 investigational new drug applications for cell and gene therapies by 2020, causing the agency to strengthen its regulatory program.
Considering Alternative Dosage Forms in Biologics
March 01, 2019
Cover Story
32
3
Optimizing the patient experience and technological advances can positively impact adherence.
Test Methods and Quality Control for Prefilled Syringes
March 01, 2019
Features
32
3
Both empty and filled syringes must pass a range of tests to meet quality standards for biopharmaceutical drugs.
Is Simplification Aiding Data Integrity Compliance?
March 01, 2019
Ask the Expert
32
3
Simplification is crucial to maintain data integrity, according to Siegfried Schmitt, PhD, vice-president, technical at PAREXEL Consulting.
Caught in a Conundrum
March 01, 2019
From the Editor
32
3
Do patients get what they pay for when they demand cheaper drugs?
Process Validation Sets the Stage for Ongoing Manufacturing Quality
March 01, 2019
Features
32
3
A properly designed validation program will detect variation and ensure control based on process risk.
Real-Time Characterization of Biotherapeutics and Comparability of Biosimilars
March 01, 2019
Features
32
3
A major advantage of SPR-based analysis is its ability to estimate the association and dissociation rate constants, an advancement over the traditional steady-state analysis of biomolecules.
The Expanding Landscape of Commercial Single-Use Bioreactors
March 01, 2019
Features
32
3
A look at recent investments by contract manufacturers to increase single-use bioreactor capacity.
Membrane Technology for Enhancing Separation and Purification
March 01, 2019
Features
32
3
Downstream process equipment for mAbs manufacturing must be designed to fit technology developments in upstream processes.
Automating the Biomanufacturing Process
March 01, 2019
Features
32
3
As automation in biomanufacturing becomes more important, so does the need to integrate process data.
BioPharm International, March 2019 Issue (PDF)
March 01, 2019
Issue PDF
32
3
Click the title above to open the BioPharm International March 2019 issue in an interactive PDF format.